Related Experiment Videos
An immunological factor that affects Anopheles gambiae survival
B H Noden1, J A Vaughan, M S Ibrahim
1Department of Molecular Microbiology and Immunology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Journal of the American Mosquito Control Association
|March 1, 1995
Summary
Antibodies targeting mosquito midguts showed surprising results. One rabbit serum killed Anopheles gambiae, but the mosquitocidal factor was not IgG mediated, challenging vaccine development.
Area of Science:
- Immunology
- Vector Biology
- Vaccine Development
Background:
- Development of effective antimosquito vaccines is crucial for malaria control.
- Identifying specific mosquito targets is key for vaccine efficacy.
Purpose of the Study:
- To produce antibodies against Anopheles gambiae midguts.
- To identify potential midgut targets for an antimosquito vaccine.
Main Methods:
- New Zealand rabbits were immunized to produce high-titer antibodies against Anopheles gambiae midguts.
- Serum R2B6 was tested for its ability to kill Anopheles gambiae and other mosquito species.
- Mosquitoes were analyzed for nutrient absorption, oviposition, and egg hatching rates after ingesting serum.
- The mosquitocidal factor was characterized by molecular weight and its dependence on complement and IgG.
Main Results:
- Serum R2B6 from one rabbit killed 71.6% of Anopheles gambiae within 7 days.
- Mosquitoes ingesting R2B6 serum exhibited impaired nutrient absorption, reduced oviposition, and lower egg hatching rates.
- Anopheles stephensi and Anopheles arabiensis were also susceptible, but Anopheles freeborni, Anopheles albimanus, and Aedes aegypti were not affected.
- The mosquitocidal factor was a large molecule (>100,000 MW), complement-independent, and importantly, not IgG-mediated.
Conclusions:
- The mosquitocidal factor in R2B6 serum is not IgG-mediated, despite high antibody titers.
- This finding challenges the direct use of antibodies against whole mosquito midguts for antimosquito vaccine development.
- Further research is needed to understand the non-IgG mosquitocidal mechanism for potential vaccine strategies.